In one paragraphArticle in PNAS nexus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Saloni SinhaDivision of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Sydney J MullinDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544, USA.
Sebastian S CarverDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544, USA.
Jason SethiadiDivision of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Brigitte L HellerDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544, USA.
Funding
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM007388 · NIGMS · PRINCETON UNIVERSITY · PI CRISTEA, ILEANA M. · 1985 to 2022
$27.4MRational design and efficacy testing of vaccines against HCVR01AI168048 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI Alexander Andrianov, Thomas R Fuerst · 2022 to 2026
$7.1MGenetic Viral and Host Adaptations to Breach Species Barriers of HCVR01AI107301 · NIAID · PRINCETON UNIVERSITY · PI Thomas Pietschmann, Alexander Ploss · 2013 to 2026
$6.0MModeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infectionR01AI138797 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PLOSS, ALEXANDER, SU, LISHAN · 2018 to 2022
$3.9MData-Driven Mathematical and Computational Modeling of Hepatitis D Infection and Treatment ResponseR01AI146917 · NIAID · LOYOLA UNIVERSITY CHICAGO · PI DAHARI, HAREL · 2020 to 2024
$3.5MTargeting hepatitis B virus cccDNA during HBV/HIV co-infectionR01AI181664 · NIAID · PRINCETON UNIVERSITY · PI PLOSS, ALEXANDER · 2024 to 2025
$3.0MMechanisms of hepatitis B virus cccDNA formationR01AI153236 · NIAID · PRINCETON UNIVERSITY · PI PLOSS, ALEXANDER · 2020 to 2024
$2.8MOptimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyteR01DK121072 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI SCHWARTZ, ROBERT E · 2020 to 2024
$2.6MDevelopment of a highly-multiplexed CRISPR-based TB drug susceptibility testR01AI182281 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Cameron Amadeus Myhrvold, Yingda Linda Xie · 2024 to 2026
$2.2MModeling alcohol toxicity in human hepatocytesR01AA027327 · NIAAA · WEILL MEDICAL COLL OF CORNELL UNIV · PI DE JONG, YPE PETER · 2019 to 2023
$1.9MBD FACSymphony A3: A multi-laser analytical flow cytometer for the Princeton University Flow Cytometry Resource FacilityS10OD028592 · OD · PRINCETON UNIVERSITY · PI DECOSTE, CHRISTINA J. · 2021 to 2021
$400kSystematic dissection of viral genetic interactions and mutations with COEXPRES-SeqK99AI182471 · NIAID · PRINCETON UNIVERSITY · PI LIN, AARON ERIC · 2025 to 2025
$101kNIAAA NIH HHS R01 AA027327NIAID NIH HHS K99 AI182471NIAID NIH HHS R01 AI107301NIAID NIH HHS R01 AI138797NIAID NIH HHS R01 AI146917NIAID NIH HHS R01 AI153236NIAID NIH HHS R01 AI168048NIAID NIH HHS R01 AI181664NIAID NIH HHS R01 AI182281NIDDK NIH HHS R01 DK121072NIGMS NIH HHS T32 GM007388NIH HHS S10 OD028592
6 · The paper itselfAbstract
Usutu virus (USUV) is an emerging mosquito-borne orthoflavivirus closely related to West Nile and Japanese encephalitis viruses. Despite its increasing prevalence in Europe and reports of neuroinvasive disease in humans, the molecular and immunological determinants of USUV infection remain poorly understood, largely due to the absence of tractable experimental tools. Here, we report the generation and characterization of the first full-length fluorescent reporter USUV. Using a previously established infectious clone of the Vienna 2001 strain, we inserted the
Indexed as
drug developmenthost responsesorthoflavivirusUsutu virusUSUV
Identifiers
PMID42872074
PMCPMC13659910
What OpenQuestion holds
Textmetadata
Read underepoch 390